9th Apr 2008 07:00
Hutchison China Meditech Limited09 April 2008 Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) Annual Report 2007 and Notice of Annual General Meeting London, Wednesday, 9 April 2008: Chi-Med today announces that its Annual Report2007 together with the Notice of Annual General Meeting ("AGM") and the ProxyForm have been posted to shareholders. The documents can be accessed from thewebsite of Chi-Med (www.chi-med.com). The AGM of Chi-Med will be held at Citigate Dewe Rogerson, 3 London WallBuildings, London, EC2M 5SY on Friday, 9 May 2008 at 2:30 p.m. Ends Enquiries Chi-Med Telephone: +852 2121 8200 Christian Hogg, CEO Citigate Dewe Rogerson Telephone: +44 (0) 20 7638 9571 Anthony Carlisle +44 (0) 7973 611 888 David Dible +44 (0) 7967 566 919 About Chi-Med Chi-Med is the holding company of a pharmaceutical and healthcare group focusedon Traditional Chinese Medicine ("TCM") based primarily in China and wasadmitted to trading on the Alternative Investment Market of the London StockExchange in May 2006. Chi-Med operates three core business segments: 1) Chinahealthcare - the manufacture, distribution and marketing of pharmaceuticals andhealth supplements in China; 2) Drug R&D - the discovery and global developmentof novel drug in the oncology and auto-immune therapeutic areas; and 3) Consumerproducts - global retailing and distribution consumer health and personal careproducts derived from TCM and botanical ingredients. Chi-Med is majority owned by Hutchison Whampoa Limited, an international companylisted on the Main Board of The Stock Exchange of Hong Kong Limited. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hutchmed